ENDRA Life Sciences Inc. (NDRA)
NASDAQ: NDRA · Real-Time Price · USD
5.07
+0.36 (7.64%)
At close: Nov 20, 2024, 4:00 PM
4.870
-0.200 (-3.94%)
Pre-market: Nov 21, 2024, 7:07 AM EST

ENDRA Life Sciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
31813292513
Upgrade
Market Cap Growth
-55.00%39.49%-55.92%15.68%100.27%13.06%
Upgrade
Enterprise Value
-2156182211
Upgrade
Last Close Price
5.073710.007122.5124213.0226250.0358800.06
Upgrade
PB Ratio
0.573.171.782.703.512.64
Upgrade
P/TBV Ratio
0.573.171.782.703.512.64
Upgrade
Debt / Equity Ratio
0.040.100.100.070.110.15
Upgrade
Quick Ratio
5.833.142.876.137.332.98
Upgrade
Current Ratio
6.103.363.167.838.323.15
Upgrade
Return on Equity (ROE)
-152.50%-156.42%-146.53%-125.11%-196.57%-241.73%
Upgrade
Return on Assets (ROA)
-62.40%-82.05%-74.26%-66.42%-90.19%-94.13%
Upgrade
Return on Capital (ROIC)
-78.61%-93.19%-84.38%-73.64%-107.05%-115.24%
Upgrade
Earnings Yield
-334.13%-56.13%-102.57%-38.53%-46.53%-105.74%
Upgrade
FCF Yield
-53.47%-100.96%-38.31%-42.94%-68.60%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.